Sharon Connaughton

Special Counsel
Full contact info

Experience

Rubrik Announces $752 Million Upsized IPO

April 29, 2024

Cooley advised Rubrik, the Zero Trust Data Security Company delivering data security and operational resilience for enterprises, on its $752 million initial public offering. Rubrik issued and sold 23,500,000 shares of Class A common stock priced at $32 per share, with a 30-day option for the underwriters to purchase up to 3,525,000 additional shares of Class A common stock.

Read more

Related contacts

Jon Avina
Partner, Palo Alto
Calise Cheng
Partner, Palo Alto
Milson Yu
Partner, Palo Alto
Dee Bansal
Partner, Washington, DC
Rebekah Donaleski
Partner, New York
TJ Graham
Partner, Palo Alto
Daniel Grooms
Partner, Washington, DC
Natasha Kaye
Partner, London
Charlie Kim
Partner, San Diego
Travis LeBlanc
Partner, Washington, DC
Eileen Marshall
Partner, Washington, DC
Joshua Mates
Partner, San Francisco
Alessandra Murata
Partner, Palo Alto
Michael Tollini
Partner, Washington, DC
Lei Shen
Partner, Chicago
Mark Windfeld-Hansen
Senior Counsel, Palo Alto
Francis Wheeler
Partner, Colorado
Sharon Connaughton
Special Counsel, Washington, DC
Dani Nazemian
Special Counsel, San Diego
Karen Tsai
Special Counsel, Washington, DC
Alanna Anderson
Associate, Palo Alto

Related Practices & Industries

ARCH Venture Partners Co-Leads Xaira Therapeutics $1 Billion Series A Funding

April 24, 2024

Cooley advised ARCH Venture Partners, which co-led a $1 billion Series A funding round in Xaira Therapeutics. Partners Colleen Badgley, Danielle Naftulin and Dave Peinsipp led the Cooley team advising ARCH, a venture capital firm catalyzing discoveries that prevent, detect and cure disease.

Related contacts

David Peinsipp
Partner, San Francisco
Colleen Badgley
Partner, Seattle
Danielle Naftulin
Partner, Palo Alto
Willy Cowles
Associate, Seattle
Bill Christiansen
Partner, Seattle
Dr. Tian Yong Zheng
Patent Agent, Seattle
Chen Chen
Associate, Palo Alto
Bin Wang
Special Counsel, Palo Alto
Zack Gong
Associate, Shanghai
Tom James
Associate, San Francisco
Thomas Welk
Senior Counsel, San Diego
Carly Robinson
Associate, Reston
Sharon Connaughton
Special Counsel, Washington, DC

Related Practices & Industries

Payapps to Be Acquired by Autodesk

January 26, 2024

Cooley advised cloud-based construction software company Payapps and its private equity sponsor IFM Investors on a definitive agreement in which Payapps will be acquired by Autodesk, a multinational software company.

Read more

Related contacts

David Silverman
Partner, New York
Andrew Lustig
Partner, Reston
Tommi McCarthy
Associate, New York
Well Mackey Jr
Associate
Eileen Marshall
Partner, Washington, DC
Patrick Sharma
Associate, Los Angeles Santa Monica
Len Jacoby
Partner, New York
Bomin Kim
Associate, New York
Nyron J. Persaud
Partner, New York
Mary Maher Lewis
Special Counsel, Reston
Cara Buchicchio
Associate, New York
Michael Egan
Partner, Washington, DC
Guadalupe Sampedro
Partner, London
Paula Holland
Partner, London
Thomas Connors
Partner, Boston
Christopher Kimball
Partner, Washington, DC
Gerard O'Shea
Partner, New York
David Wilson
Partner, London
Stella Sarma
Special Counsel, Brussels
Sharon Connaughton
Special Counsel, Washington, DC
Adam Fleisher
Partner, Washington, DC
Michael Gladstone
Associate, New York
Morgan McCormack
Associate, London
Jia Xie
Associate, London
Allison Kutner
Associate, New York
DeVon Barnett
Associate, Washington, DC
Ajay Athavale
Associate, San Francisco
Richard G.S. Lee
Associate, Washington, DC
Steven A. Zuckerman
Associate, New York
Arthi Naini
Associate, New York
Patrick O. Johnson
Associate, Boston
Athina Gaki
Associate, Brussels
Leo Spicer-Phelps
Associate, London
Jarrett Burks
Associate, London
Margie Murphy
Paralegal Specialist, New York

Related Practices & Industries

Yieldstreet Completes Acquisition of Cadre

January 23, 2024

Cooley advised Yieldstreet, a leading private market investing platform, on its acquisition of Cadre, an online real estate-focused investment platform that serves institutional and high net worth investors.

Read more

Related contacts

Sacha Ross
Partner, New York
David Silverman
Partner, New York
Nathan Baum
Associate, New York
Danielle Gershowitz
Partner, New York
Sean Ruff
Partner, Washington, DC
Cristina Lombardi
Associate, New York
Daniel Chao
Associate, New York
Norris Kadet
Associate, New York
Stephanie Gentile
Partner, New York
David Walsh
Partner, Reston
Paula Fleckenstein
Associate, Reston
Patrick Flanagan
Partner, New York
Stacey Song
Partner, New York
Len Jacoby
Partner, New York
Eileen Marshall
Partner, Washington, DC
Joshua Mates
Partner, San Francisco
Zachariah A. Robert
Partner, Chicago
Tiana Demas
Partner
Todd Gluth
Partner, San Diego
Lei Shen
Partner, Chicago
Sharon Connaughton
Special Counsel, Washington, DC
Stacey A. Bradford
Special Counsel, Washington, DC
Stella Sarma
Special Counsel, Brussels
Jeff Goldman
Special Counsel, Palo Alto
Kristin O'Hanlon
Special Counsel, San Francisco
Adam Fleisher
Partner, Washington, DC
Nathaniel Hearn Jr.
Associate, Chicago
Matan Neuman
Associate, New York
Mor Agam
Associate, New York
Bomin Kim
Associate, New York
Liza Cotter
Associate, Boston
Allison Kutner
Associate, New York
Arthi Naini
Associate, New York
Steven A. Zuckerman
Associate, New York
Julie Paulino Montejo
Associate, New York
Margaret Barreto
Associate, San Francisco
Edward (Teddy) Nimetz
Associate, New York
Calvin Lee
Associate, New York
Rachel F. Katz
Associate, New York
Kristin R. Marshall
Associate, Washington, DC
Patricia Myers
Paralegal Specialist, Colorado
Loraine Torres
Paralegal Specialist, Colorado
Margie Murphy
Paralegal Specialist, New York

Related Practices & Industries

Allorion Therapeutics Announces Exclusive Option, Global License Agreement With AstraZeneca

January 2, 2024

Cooley advised Allorion Therapeutics, a US- and China-based biotechnology company that focuses on the discovery of new small molecule drugs for treating cancer and autoimmune diseases, on its exclusive option and global license agreement with AstraZeneca to develop and commercialize a novel epidermal growth factor receptor (EGFR) L858R mutated allosteric inhibitor as a potential new treatment for advanced EGFR-mutant non-small-cell lung cancer.

Read more

Related contacts

Marya Postner
Partner, Palo Alto
Brendan Haberle
Associate, San Diego
Yiming Liu
Partner in Charge – Shanghai, Shanghai
Jameson Davis
Associate, Boston
Xander Lee
Partner, Los Angeles Santa Monica
Mor Agam
Associate, New York
Sharon Connaughton
Special Counsel, Washington, DC
Rachel Thorn
Partner, New York
Elizabeth Anne Wright
Of Counsel, Brussels
Natasha Leskovsek
Of Counsel, Washington, DC
Jessica Koffel
Associate, Brussels
Robert Eisenbach
Of Counsel, San Francisco

Related Practices & Industries

View more

Admissions & credentials

District of Columbia

Virginia